The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Prognostic Factors in Non-small Cell Lung Cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
Revisions in the International System for Staging Lung Cancer
Mountain, C. F. (1997) · Chest · doi:10.1378/chest.111.6.1710 · Cited by 4,565
Non-small Cell Lung Cancer Collaborative Group (1995) · BMJ · doi:10.1136/bmj.311.7010.899 · Cited by 2,850
Regional Lymph Node Classification for Lung Cancer Staging
Mountain, C. F., & Dresler, C. M. (1997) · Chest · doi:10.1378/chest.111.6.1718 · Cited by 1,439
Incidence of local recurrence and second primary tumors in resected stage I lung cancer
Martini, N., Bains, M. S., Burt, M. E., Zakowski, M. F., McCormack, P., Rusch, V. W., & Ginsberg, R. J. (1995) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(95)70427-2 · Cited by 973
Yódice, A., & CHIARE, F. L. (1954) · PubMed · Cited by 836
K-ras Oncogene Activation as a Prognostic Marker in Adenocarcinoma of the Lung
Slebos, R. J. C., Kibbelaar, R. E., Dalesio, O., Kooistra, A., Stam, J., Meijer, C. J. L. M., Wagenaar, S. S., Vanderschueren, R. G. J. R. A., van Zandwijk, N., Mooi, W. J., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008303230902 · Cited by 809
Albain, K. S., Crowley, J. J., LeBlanc, M., & Livingston, R. B. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.9.1618 · Cited by 728
Buccheri, G., Ferrigno, D., & Tamburini, M. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00664-8 · Cited by 629
Andre, F., Grunenwald, D., Pignon, J.-P., Dujon, A., Pujol, J. L., Brichon, P. Y., Brouchet, L., Quoix, E., Westeel, V., & Le Chevalier, T. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.2981 · Cited by 484
p185neu expression in human lung adenocarcinomas predicts shortened survival.
Kern, J. A., Schwartz, D. A., Nordberg, J. E., Weiner, D. B., Greene, M. I., Torney, L., & Robinson, R. A. (1990) · PubMed · Cited by 466
Vansteenkiste, J. F., Stroobants, S. G., Dupont, P. J., De Leyn, P. R., Verbeken, E. K., Deneffe, G. J., Mortelmans, L. A., & Demedts, M. G. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3201 · Cited by 439
Cancer: Principles and Practice of Oncology
Levi, J. A. (1987) · Pathology · doi:10.1016/s0031-3025(16)39749-5 · Cited by 404
Paesmans, M., Sculier, J. P., Libert, P., Bureau, G., Dabouis, G., Thiriaux, J., Michel, J., Van Cutsem, O., Sergysels, R., & Mommen, P. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.5.1221 · Cited by 386
Accumulation of p53 protein correlates with a poor prognosis in human lung cancer.
Quinlan, D. C., Davidson, A. G., Summers, C. L., Warden, H. E., & Doshi, H. M. (1992) · PubMed · Cited by 383
Clinical significance of ras oncogene activation in human lung cancer
(1993) · Lung Cancer · doi:10.1016/0169-5002(93)90536-7 · Cited by 360
堀尾, 芳. (1995) · Medical Entomology and Zoology · doi:10.11501/3102283 · Cited by 352
Quality of life assessment. An independent prognostic variable for survival in lung cancer
Ganz, P. A., Jack Lee, J., & Siau, J. (1991) · Cancer · doi:10.1002/1097-0142(19910615)67:12<3131::aid-cncr2820671232>3.0.co;2-4 · Cited by 349
Mitsudomi, T., Hamajima, N., Ogawa, M., & Takahashi, T. (2000) · PubMed · Cited by 341
Coates, A., Porzsolt, F., & Osoba, D. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00049-x · Cited by 327
Tang, X. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1511 · Cited by 314
Deitch, R. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92618-7 · Cited by 309
Fontanini, G., Vignati, S., Boldrini, L., Chinè, S., Silvestri, V., Lucchi, M., Mussi, A., Angeletti, C. A., & Bevilacqua, G. (1997) · PubMed · Cited by 306
Fontanini, G., Laurentiis, M. D., Vignati, S., Chinè, S., Lucchi, M., Silvestri, V., Mussi, A., Placido, S. D., Tortora, G., Bianco, A. R., et al. (1998) · PubMed · Cited by 306
Fontanini, G., Vignati, S., Basolo, F., Bevilacqua, G., Lucchi, M., Mussi, A., Angeletti, C. A., Ciardiello, F., De Laurentiis, M., & De Placido, S. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.12.881 · Cited by 300
Quality of life in lung cancer patients
Montazeri, A., Milroy, R., Hole, D., McEwen, J., & Gillis, C. R. (2001) · Lung Cancer · doi:10.1016/s0169-5002(00)00179-3 · Cited by 290
Harpole, D. H., Herndon, J. E., Wolfe, W. G., Iglehart, J. D., & Marks, J. R. (1995) · PubMed · Cited by 290
O'Byrne, K. J., Koukourakis, M. I., Giatromanolaki, A., Cox, G., Turley, H., Steward, W. P., Gatter, K., & Langrish, V (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1129 · Cited by 275
van Rens, M. T. M., van den Bosch, J. M. M., Brutel de la Rivière, A., & Elbers, H. R. J. (2000) · Chest · doi:10.1378/chest.117.2.374 · Cited by 273
Gail, M. H., Eagan, R. T., Feld, R., Ginsberg, R., Goodell, B., Hill, L., Holmes, E. C., Lukeman, J. M., Mountain, C. F., Oldham, R. K., et al. (1984) · Cancer · doi:10.1002/1097-0142(19841101)54:9<1802::aid-cncr2820540908>3.0.co;2-4 · Cited by 270
Ohsaki, Y., Tanno, S., Fujita, Y., Toyoshima, E., Fujiuchi, S., Nishigaki, Y., Ishida, S., Nagase, A., Miyokawa, N., Hirata, S., et al. (2000) · Oncology Reports · doi:10.3892/or.7.3.603 · Cited by 254
Mitsudomi, T., Steinberg, S. M., Oie, H. K., Mulshine, J. L., Phelps, R. M., Viallet, J., Pass, H. I., Minna, J. D., & Gazdar, A. F. (1991) · PubMed · Cited by 248
D'Amico, M., Massey, M., Herndon II, P., Moore, M.-B., & Harpole, D. H. (1999) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(99)70294-1 · Cited by 233
Implications and Prognostic Value of K-ras Mutation for Early-Stage Lung Cancer in Women
Nelson, H. H., Christiani, D. C., Mark, E. J., Wiencke, J. K., Wain, J. C., & Kelsey, K. T. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.23.2032 · Cited by 227
Expression of Blood-Group Antigen A — A Favorable Prognostic Factor in Non-Small-Cell Lung Cancer
Lee, J. S., Ro, J. Y., Sahin, A. A., Hong, W. K., Brown, B. W., Mountain, C. F., & Hittelman, W. N. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104183241603 · Cited by 221
Betticher, D., Heighway, J., Hasleton, P., Altermatt, H., Ryder, W., Cerny, T., & Thatcher, N. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.52 · Cited by 219
Veale, D., Kerr, N., Gibson, G., Kelly, P., & Harris, A. L. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.306 · Cited by 219
Han, H., Silverman, J. F., Santucci, T. S., Macherey, R. S., dAmato, T. A., Tung, M. Y., Weyant, R. J., & Landreneau, R. J. (2001) · Annals of Surgical Oncology · doi:10.1007/s10434-001-0072-y · Cited by 213
Mitsudomi, T., Oyama, T., Kusano, T., Osaki, T., Nakanishi, R., & Shirakusa, T. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.24.2018 · Cited by 211
Yuan, A., Yu, C.-J., Kuo, S.-H., Chen, W.-J., Lin, F.-Y., Luh, K.-T., Yang, P.-C., & Lee, Y.-C. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.432 · Cited by 207
(2000) · PubMed · Cited by 206
Kase, S., Sugio, K., Yamazaki, K., Okamoto, T., Yano, T., & Sugimachi, K. (2000) · PubMed · Cited by 199
Herndon, J. E., Fleishman, S., Kornblith, A. B., Kosty, M., Green, M. R., & Holland, J. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990115)85:2<333::aid-cncr10>3.0.co;2-q · Cited by 193
Schiller, J. H., Adak, S., Feins, R. H., Keller, S. M., Fry, W. A., Livingston, R. B., Hammond, M. E. M., Wolf, B., Sabatini, L., Jett, J., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.448 · Cited by 192
Compton, C. (2002) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2002-126-384a-pfic · Cited by 185
Kubuschok, B., Passlick, B., Izbicki, J. R., Thetter, O., & Pantel, K. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.19 · Cited by 183
Volm, M., Rittgen, W., & Drings, P. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.106 · Cited by 178
YUAN, A., YANG, P.-C., YU, C.-J., CHEN, W.-J., LIN, F.-Y., KUO, S.-H., & LUH, K.-T. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.5.2002108 · Cited by 173
Siegfried, J. M., Weissfeld, L. A., Singh-Kaw, P., Weyant, R. J., Testa, J. R., & Landreneau, R. J. (1997) · PubMed · Cited by 164
Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor
Manac'h, D., Riquet, M., Médioni, J., Pimpec‐Barthes, F. L., Dujon, A., & Danel, C. J. (2001) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(00)02649-7 · Cited by 162
Apolinario, R. M., van der Valk, P., de Jong, J. S., Deville, W., van Ark-Otte, J., Dingemans, A. M., van Mourik, J. C., Postmus, P. E., Pinedo, H. M., & Giaccone, G. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2456 · Cited by 161
Suzuki, K., Nagai, K., Yoshida, J., Nishimura, M., Takahashi, K., Yokose, T., & Nishiwaki, Y. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991115)86:10<1976::aid-cncr14>3.0.co;2-i · Cited by 141
Müller‐Tidow, C., Metzger, R., Kügler, K., Diederichs, S., Idos, G., Thomas, M., Dockhorn‐Dworniczak, B., Schneider, P. M., Koeffler, H. P., Berdel, W. E., et al. (2001) · PubMed · Cited by 136
Passlick, B., Sienel, W. G. R., Seen-Hibler, R., Wöckel, W., Thetter, O., Mutschler, W., & Pantel, K. (2000) · PubMed · Cited by 134
Fontanini, G., Vignati, S., Lucchi, M., Mussi, A., Calcinai, A., Boldrini, L., Chinè, S., Silvestri, V., Angeletti, C. A., Basolo, F., et al. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.220 · Cited by 127
Natural Autoantibody to MUC1 Is a Prognostic Indicator for Non–Small Cell Lung Cancer
Hirasawa, Y., Kohno, N., Yokoyama, A., KONDO, K., Hiwada, K., & Miyake, M. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.9905028 · Cited by 127
Fujisawa, T., Iizasa, T., Saitoh, Y., Sekine, Y., Motohashi, S., Yasukawa, T., Shibuya, K., Hiroshima, K., & Ohwada, H. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.7.2086 · Cited by 124
Depressive reactions to lung cancer are common and often followed by a poor outcome.
Buccheri, G. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.11010173 · Cited by 122
Bourke, W., Milstein, D., Giura, R., Donghi, M., Luisetti, M., Rubin, A. E., & Smith, L. J. (1992) · CHEST Journal · doi:10.1378/chest.102.6.1723 · Cited by 117
CD133 expression: a potential prognostic marker for non-small cell lung cancers
Mizugaki, H., Sakakibara‐Konishi, J., Kikuchi, J., Moriya, J., Hatanaka, K. C., Kikuchi, E., Kinoshita, I., Oizumi, S., Dosaka‐Akita, H., Matsuno, Y., et al. (2013) · International Journal of Clinical Oncology · doi:10.1007/s10147-013-0541-x · Cited by 115
Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.
Hommura, F., Dosaka‐Akita, H., Mishina, T., Nishi, M., Kojima, T., Hiroumi, H., Ogura, S., Shimizu, M., Katoh, H., & Kawakami, Y. (2000) · PubMed · Cited by 110
Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer.
Marchetti, A., Bertacca, G., Buttitta, F., Chella, A., Quattrocolo, G., Angeletti, C. A., & Bevilacqua, G. (1999) · PubMed · Cited by 110
Hashimoto, T., Tokuchi, Y., Hayashi, M., Kobayashi, Y., 西田, 一., Hayashi, S., Ishikawa, Y., Tsuchiya, S., Nakagawa, K., Hayashi, J., et al. (1999) · PubMed · Cited by 109
Do Molecular Markers Predict Survival in Non–Small-Cell Lung Cancer?
Greatens, T. M., Niehans, G. A., Rubins, J. B., Jessurun, J., Kratzke, R. A., Maddaus, M. A., & Niewoehner, D. E. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9707108 · Cited by 104
Takanami, I., Tanana, F., Hashizume, T., et al. (2009) · Oncology · doi:10.1159/000227594 · Cited by 100
Prognostic significance of plasma D-dimer levels in patients with lung cancer
Taguchi, O., Gabazza, E. C., Yasui, H., Kobayashi, T., Yoshida, M., & Kobayashi, H. (1997) · Thorax · doi:10.1136/thx.52.6.563 · Cited by 100
Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data
Choma, D., Daurès, J., Quantin, X., & Pujol, J. L. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1892 · Cited by 99
Lung cancer treatment decisions: patients’ desires for participation and information
Davidson, J. R., Brundage, M., & Feldman‐Stewart, D. (1999) · Psycho-Oncology · Cited by 96
Self-citationPrognostic significance of Ki67 labelling in resected non small cell lung cancer
Scagliotti, G. V., Micela, M., Gubetta, L., Leonardo, E., Cappia, S., Borasio, P., & Pozzi, E. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90387-u · Cited by 94
Predictive factors in radiotherapy for non-small cell lung cancer: present status
Choi, N. C., Baumann, M. A., Flentjie, M., Kellokumpu‐Lehtinen, P., Senan, S., Zamboglou, N., & Kosmidis, P. (2001) · Lung Cancer · doi:10.1016/s0169-5002(00)00156-2 · Cited by 92
Dosaka‐Akita, H., Hu, S., Fujino, M., Harada, M., Kinoshita, I., Xu, H., Kuzumaki, N., Kawakami, Y., & Benedict, W. F. (1997) · PubMed · Cited by 91
p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung.
Komiya, T., Hosono, Y., Hirashima, T., Masuda, N., Yasumitsu, T., Nakagawa, K., Kikui, M., Ohno, A., Fukuoka, M., & Kawase, I. (1997) · PubMed · Cited by 89
Ichinose, Y., Hara, N., Ohta, M., Yano, T., 前田, 和., Asoh, H., & Katsuda, Y. (1993) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)33744-4 · Cited by 89
Takigawa, N., Segawa, Y., Okahara, M., et al. (1996) · Lung Cancer · doi:10.1016/0169-5002(96)00571-5 · Cited by 88
Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis.
Pelletier, M. P., Edwardes, M., Michel, R. P., Halwani, F., & Morin, J. E. (2001) · Europe PMC (PubMed Central) · Cited by 88
Survival predictors in advanced non-small cell lung cancer
Hespanhol, V. P., Queiroga, H., Magalhães, A., Santos, A. R., Coelho, M., & Marqués, J. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)00497-1 · Cited by 85
Skaug, V., Ryberg, D., Kure, E. H., Arab, M. O., Stangeland, L. B., Myking, A. O., & Haugen, A. (2000) · PubMed · Cited by 85
Schneider, P. M., Praeuer, H. W., Stoeltzing, O., Boehm, J., Manning, J. T., Metzger, R., Fink, U., Wegerer, S., Hoelscher, A. H., & Roth, J. A. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1287 · Cited by 81
Ichinose, Y., Hara, N., Ohta, M., et al. (1993) · PubMed · Cited by 80
Huang, C., Taki, T., Adachi, M., Konishi, T., Higashiyama, M., & Miyake, M. (1998) · Oncogene · doi:10.1038/sj.onc.1201776 · Cited by 79
Prognostic Impact of Telomerase Activity in Non-Small Cell Lung Cancers
Taga, S., Osaki, T., Ohgami, A., Imoto, H., & Yasumoto, K. (1999) · Annals of Surgery · doi:10.1097/00000658-199911000-00015 · Cited by 78
Prognostic Significance of the Proliferation Index in Surgically Resected Non—Small-Cell Lung Cancer
Pence, J. C. (1993) · Archives of Surgery · doi:10.1001/archsurg.1993.01420240090017 · Cited by 76
Prognostic significance of polysialic acid expression in resected non-small cell lung cancer.
Tanaka, F., Otake, Y., Nakagawa, T., Kawano, Y., Miyahara, R., Li, M., Yanagihara, K., Inui, K., Oyanagi, H., Yamada, T., et al. (2001) · PubMed · Cited by 76
Cytokeratins as Serum Markers in Lung Cancer: A Comparison of CYFRA 21-1 and TPS
Pujol, J.-L., Grenier, J., Parrat, É., Lehmann, M., Lafontaine, T., Quantin, X., & Michel, F. B. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.3.8810612 · Cited by 74
Fujisawa, T., & Yamaguchi, Y. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970201)79:3<474::aid-cncr8>3.0.co;2-i · Cited by 72
Shiba, M., Kohno, H., Kakizawa, K., Iizasa, T., Otsuji, M., Saitoh, Y., Hiroshima, K., Ohwada, H., & Fujisawa, T. (2000) · Cancer · doi:10.1002/1097-0142(20001001)89:7<1457::aid-cncr7>3.0.co;2-l · Cited by 72
Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer.
Huang, C., Taki, T., Adachi, M., Konishi, T., Higashiyama, M., Kinoshita, M., Hadama, T., & Miyake, M. (1998) · International Journal of Oncology · doi:10.3892/ijo.12.3.553 · Cited by 72
MDM2 mRNA expression is a favorable prognostic factor in non-small-cell lung cancer
Ko, J., Cheng, Y., Chang, S.-L., Su, J.-M., Chen, C., & Lee, H. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000520)89:3<265::aid-ijc9>3.0.co;2-n · Cited by 72
XIV. The purposes of prognostic stratification
Feinstein, A. R. (1972) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1972132285 · Cited by 72
(2000) · doi:10.1002/1096-9896(2000)9999:9999 · Cited by 70
Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer
Carles, J., Rosell, R., Ariza, A., Pellicer, I., Sanchez, J. J., Fernandez-Vasalo, G., Abad, A., & Barnadas, A. (1993) · Lung Cancer · doi:10.1016/0169-5002(93)90181-v · Cited by 70
p53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer
Vega, F., Iniesta, P., Caldés, T., Sánchez, A., López, J., de Juan, C., Díaz‐Rubio, E., Torres, A., Jl, B., & Benito, M. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.334 · Cited by 70
Relationship between vascularity, age and survival in non-small-cell lung cancer
Chandrachud, L. M., Pendleton, N., CHISHOLM, D. M., Horan, M. A., & Schor, A. M. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.562 · Cited by 69
Evaluation of TMN classification for lung carcinoma with ipsilateral intrapulmonary metastasis
Okada, M., Tsubota, N., Yoshimura, M., Miyamoto, Y., & Nakai, R. (1999) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(99)00465-8 · Cited by 65
Antineural and antinuclear autoantibodies are of prognostic relevance in non-small cell lung cancer
Blaes, F., Klotz, M., Huwer, H., Straub, U., Kalweit, G. A., Schimrigk, К., & Schäfers, H. (2000) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(99)01198-4 · Cited by 65
Prognostic Significance of Apoptotic Index in Completely Resected Non–Small-Cell Lung Cancer
Tanaka, F., Kawano, Y., Li, M., Takata, T., Miyahara, R., Yanagihara, K., Ohtake, Y., Fukuse, T., & Wada, H. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2728 · Cited by 65
Pantel, K., Passlick, B., Vogt, J., Stosiek, P., Angstwurm, M., Seen-Hibler, R., Häussinger, K., Thetter, O., Izbicki, J. R., & Riethmüller, G. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1407 · Cited by 62
Pleural effusion as a significant prognostic factor in non-small cell lung cancer.
Naito, T., Satoh, H., Ishikawa, H. T., et al. (1998) · PubMed · Cited by 62
Brundage, M., Davidson, J. R., Mackillop, W. J., Feldman‐Stewart, D., & Groome, P. A. (1998) · Medical Decision Making · doi:10.1177/0272989x9801800302 · Cited by 60
Self-citationA novel molecular staging protocol for non-small cell lung cancer
Miyake, M., Adachi, M., Huang, C., Higashiyama, M., Kodama, K., & Taki, T. (1999) · Oncogene · doi:10.1038/sj.onc.1202556 · Cited by 60
Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor.
Hirata, T., Fukuse, T., Naiki, H., Hitomï, S., & Wada, H. (1998) · PubMed · Cited by 57
Phase I Study of a Decision Aid for Patients With Locally Advanced Non–Small-Cell Lung Cancer
Brundage, M., Feldman‐Stewart, D., Cosby, R., Gregg, R. W., Dixon, P., Youssef, Y., Davies, D. L., & Mackillop, W. J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1326 · Cited by 56
Self-citationKawasaki, M., Nakanishi, Y., Kuwano, K., Yatsunami, J., Takayama, K., & Hara, N. (1997) · PubMed · Cited by 55
Boldrini, L., Calcinai, A., Samaritani, E., Pistolesi, F., Mussi, A., Lucchi, M., Angeletti, C. A., Basolo, F., & Fontanini, G. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1345 · Cited by 54
Vassilakopoulos, T., Troupis, T. G., Sotiropoulou, C., Zacharatos, P., Katsaounou, P. A., Parthenis, D. G., Noussia, O., Troupis, G., Papiris, S. A., Kittas, C. N., et al. (2001) · Lung Cancer · doi:10.1016/s0169-5002(00)00225-7 · Cited by 53
Lee, T., Horner, R. D., Silverman, J. F., Chen, Y.-H., Jenny, C., & Scarantino, C. W. (1989) · Cancer · Cited by 51
Variations in the management and outcome of non-small cell lung cancer in Ontario
Mackillop, W. J., Dixon, P., Zhou, Y., et al. (1994) · Radiotherapy and Oncology · doi:10.1016/0167-8140(94)90096-5 · Cited by 51
Self-citationÅberg, T. (1997) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(97)00006-4 · Cited by 51
Higashiyama, M., Doi, O., Kodama, K., Yokouchi, H., Adachi, M., Huang, C., Taki, T., Kasugai, T., Ishiguro, S., Nakamori, S., et al. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970422)74:2<205::aid-ijc12>3.0.co;2-c · Cited by 50
p16 protein expression is associated with a poor prognosis in squamous cell carcinoma of the lung
Huang, C.-I., Taki, T., Higashiyama, M., Kohno, N., & Miyake, M. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0929 · Cited by 49
Dalquen, P., Sauter, G., Torhorst, J. K. H., Schultheiss, E., Jordan, P., LEHMANN, S., SOLÈR, M., Stulz, P. M., Mihatsch, M. J., & Gudat, F. G. (1996) · The Journal of Pathology · Cited by 48
Huncharek, M. S., Kupelnick, B., Geschwind, J. F., et al. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00381-5 · Cited by 47
Yoshino, I., Nakanishi, R., Osaki, T., Takenoyama, M., Taga, S., Hanagiri, T., & Yasumoto, K. (1999) · CHEST Journal · doi:10.1378/chest.116.1.144 · Cited by 43
Hommura, F., Dosaka‐Akita, H., Kinoshita, I., Mishina, T., Hiroumi, H., Ogura, S., Katoh, H., & Kawakami, Y. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690750 · Cited by 40
Hirashima, T., Komiya, T., Nitta, T., et al. (2000) · PubMed · Cited by 36
New prognostic factors in resectable non-small cell lung cancer.
Smit, E. F., Groen, H. J. M., Splinter, T. A. W., Ebels, T., & Postmus, P. E. (1996) · Thorax · doi:10.1136/thx.51.6.638 · Cited by 36
The Importance of Prognosis in Cancer Medicine
Mackillop, W. J. (2006) · Wiley eBooks · doi:10.1002/0471463736.tnmp01.pub2 · Cited by 34
Self-citationPrognostic Biomarker Study in Pathologically Staged N1 Non-Small Cell Lung Cancer
Komaki, R. U., Milas, L., Ro, J. Y., Fujii, T., Perkins, P., Allen, P. K., Sikes, C. R., Mountain, C. F., & Ordóǹez, N. G. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00898-5 · Cited by 33
Fontanini, G., Vignati, S., Bigini, D., Mussi, A., Lucchi, M., Chinè, S., Angeletti, C. A., & Bevilacqua, G. (1996) · PubMed · Cited by 30
Establishment of xenografts and cell lines from well-differentiated human thyroid carcinoma
Lin, J., Chao, T., Weng, H., Huang, H.-S., & Ho, Y. (1996) · Journal of Surgical Oncology · doi:10.1002/(sici)1096-9098(199610)63:2<99::aid-jso6>3.0.co;2-j · Cited by 30
Value of Serum Neuron-Specific Enolase in Nonsmall Cell Lung Cancer
Diez, M., Torres, A., Ortega, L. M., Maestro, M. L., Hernándo, F., Gomez, A. G., Picardo, A. L., Granell, J., & Balibrea, J. L. (2009) · Oncology · doi:10.1159/000227163 · Cited by 28
Neural networks as a prognostic tool for patients with non-small cell carcinoma of the lung.
Bellotti, M., Elsner, B., Paez De Lima, A., Esteva, H., & Marchevsky, A. M. (1997) · PubMed · Cited by 28
Prognosis of ipsilateral intrapulmonary metastases in resected nonsmall cell lung cancer
Fukuse, T. (1997) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/s1010-7940(97)00122-x · Cited by 26
Tanaka, F., Yanagihara, K., Ohtake, Y., MIYAHARA, R., 河野洋三, Fukuse, T., Hitomï, S., & Wada, H. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00766.x · Cited by 25
Insulin-like growth factor-II as a prognostic factor in pulmonary adenocarcinoma
Takanami, I., Imamuma, T., Hashizume, T., Kikuchi, K., Yamamoto, Y., Yamamoto, T., & Kodaira, S. (1996) · Journal of Surgical Oncology · Cited by 22
p53 gene mutation and protein expression in operable non-small cell lung cancer in Poland
Niklińska, W., Burzykowski, T., Chyczewski, L., Rusin, M., Furman, M., Laudanski, J., Chyczewska, E., Sulik, M., & Nikliński, J. (2000) · European Journal of Cancer Prevention · doi:10.1097/00008469-200004000-00003 · Cited by 9
The value of quality of life scores in clinical cancer research
Selby, P. J. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90098-z · Cited by 5
Cited by
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji237 · Cited by 2,162
REporting recommendations for tumour MARKer prognostic studies (REMARK).
for the Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics, McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602678 · Cited by 1,394
“Such reporting deficiencies are increasingly being highlighted by systematic reviews of the published literature on particular markers or cancers [19–25].”
BackgroundReporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
Altman, D. G., McShane, L. M., Sauerbrei, W., & Taube, S. E. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001216 · Cited by 1,013
The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends
Youlden, D. R., Cramb, S. M., & Baade, P. D. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31818020eb · Cited by 812
REporting recommendations for tumor MARKer prognostic studies (REMARK)
McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9242-8 · Cited by 809
Metadata
- Authors
- Brundage, M. D., Davies, D., & Mackillop, W. J.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2002-09
- Volume
- 122
- Issue
- 3
- Pages
- 1037-1057
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2133040355
- Cited by
- 564
- References
- 128
- FWCI
- 21.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.